申请人:Hoffmann-La Roche Inc.
公开号:US05837708A1
公开(公告)日:1998-11-17
Compounds of the formula ##STR1## wherein the variables are hereinbelow defined. The compounds of formula I are inhibitors for endothelin receptors. They can be used for the treatment of disorders which are associated with endothelin activities, especially circulatory disorders such as hypertension, ischaemia, vasospasms and angina pectoris.
式子为##STR1##的化合物,其中变量如下所定义。公式I的化合物是内皮素受体抑制剂。它们可用于治疗与内皮素活动有关的疾病,特别是循环系统疾病,如高血压,缺血,血管痉挛和心绞痛。